AACR 2025 Recap: Immunotherapy Shifts, ctDNA Surveillance, and Breakthroughs in HER2 and AML

Curie: Healthcare in Focus
05/05/2025 9 min Temporada 1 Episodio 33
AACR 2025 Recap: Immunotherapy Shifts, ctDNA Surveillance, and Breakthroughs in HER2 and AML

Listen "AACR 2025 Recap: Immunotherapy Shifts, ctDNA Surveillance, and Breakthroughs in HER2 and AML"

Descargar episodio Ver en sitio original

Episode Synopsis

In this post-conference episode, Mike breaks down five major stories from AACR 2025:KEYNOTE-689 trial changes the standard of care in head and neck cancerZongertinib delivers HER2-targeted efficacy with fewer side effects in lung cancerCAR NK cells show durable remission in AMLctDNA testing in CRC detects recurrence 6+ months before imagingWerner helicase inhibitor shows first-in-class potential in MSI tumorsListen in for a concise roundup of the data and why it matters.

More episodes of the podcast Curie: Healthcare in Focus

The Preconception Revolution with Dr. Ann Shippy 04/11/2025
From Breakdown to Breakthrough - A Physician’s Reckoning with Burnout 28/10/2025
The Wellness Industrial Complex: What Influencers Reveal About Modern Medicine 21/10/2025
Autopilot Medicine: The Danger of Getting Too Good at AI 14/10/2025
Tylenol & Autism: What Clinicians Should Know (and Watch For) 07/10/2025
Replaceable You – Mary Roach on the Miracles We Can’t Copy 30/09/2025
The Great American Healthcare Heist with Chris Deacon 23/09/2025
From Bedside to Boardroom - Krista Bragg on Bridging Clinician and Executive Perspectives 16/09/2025
AI Scribes – The Hidden Cost of Progress 09/09/2025
Dr. Nasser Hanna - A Life in Medicine, Mentorship, and Advocacy 26/08/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA